» Authors » Pavel P Laktionov

Pavel P Laktionov

Explore the profile of Pavel P Laktionov including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 81
Citations 1551
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Nazarkina Z, Stepanova A, Savostyanova T, Laktionov P
Cytotechnology . 2024 Dec; 77(1):9. PMID: 39619881
The development of new compounds or materials for medicine suggests a study of their cytotoxicity. The effect of a material on cell viability can be evaluated by several methods based...
2.
Chernonosova V, Osipova O, Nuankai Z, Shundrina I, Murashov I, Larichev Y, et al.
Biomed Mater . 2024 Sep; 19(6). PMID: 39255825
Bioengineered vascular grafts (VGs) have emerged as a promising alternative to the treatment of damaged or occlusive vessels. It is thought that polyurethane (PU)-based scaffolds possess suitable hemocompatibility and biomechanics...
3.
Nazarkina Z, Stepanova A, Chelobanov B, Kvon R, Simonov P, Karpenko A, et al.
Int J Mol Sci . 2023 Apr; 24(7). PMID: 37047685
To vectorize drug delivery from electrospun-produced scaffolds, we introduce a thin outer drug retention layer produced by electrospinning from activated carbon nanoparticles (ACNs)-enriched polycaprolacton (PCL) suspension. Homogeneous or coaxial fibers...
4.
Chernonosova V, Kuzmin I, Shundrina I, Korobeynikov M, Golyshev V, Chelobanov B, et al.
J Funct Biomater . 2023 Feb; 14(2). PMID: 36826869
Fibrous polyurethane-based scaffolds have proven to be promising materials for the tissue engineering of implanted medical devices. Sterilization of such materials and medical devices is an absolutely essential step toward...
5.
Nazarkina Z, Savostyanova T, Chelobanov B, Romanova I, Simonov P, Kvon R, et al.
Pharmaceutics . 2022 Jul; 14(7). PMID: 35890281
Activated carbon (AC) could be potentially useful as a drug carrier in fiber polymer scaffolds destined for prolonged drug delivery. To be introduced, AC must be ground into smaller-sized particles...
6.
Gostev A, Shundrina I, Pastukhov V, Shutov A, Chernonosova V, Karpenko A, et al.
Polymers (Basel) . 2022 Jun; 14(11). PMID: 35683978
The authors wish to make a change to the published paper [...].
7.
Chernonosova V, Laktionov P
Polymers (Basel) . 2022 May; 14(9). PMID: 35566866
Electrospinning is a popular method used to fabricate small-diameter vascular grafts. However, the importance of structural characteristics of the scaffold determining interaction with endothelial cells and their precursors and blood...
8.
Pryadko A, Botvin V, Mukhortova Y, Pariy I, Wagner D, Laktionov P, et al.
Polymers (Basel) . 2022 Feb; 14(3). PMID: 35160518
Novel hybrid magnetoactive composite scaffolds based on poly(3-hydroxybutyrate) (PHB), gelatin, and magnetite (FeO) were fabricated by electrospinning. The morphology, structure, phase composition, and magnetic properties of composite scaffolds were studied....
9.
Konoshenko M, Bryzgunova O, Laktionov P
Biochim Biophys Acta Rev Cancer . 2021 Sep; 1876(2):188625. PMID: 34534639
Androgen deprivation therapy (ADT) is mainly used for the treatment of advanced, metastatic or recurrent prostate cancer (PCa). However, patients progress to ADT resistance and castration-resistant prostate cancer (CRPC) with...
10.
Nazarkina Z, Chelobanov B, Kuznetsov K, Shutov A, Romanova I, Karpenko A, et al.
Polymers (Basel) . 2021 Apr; 13(7). PMID: 33916436
It was previously shown that polycaprolactone (PCL)-based electrospun-produced paclitaxel (PTX)-enriched matrices exhibit long-term drug release kinetics and can be used as coatings for drug-eluting stents (DES). The installation of vascular...